SAB Biotherapeutics, Inc.

SABS·NASDAQ·$3.81Share Price as of 11/2·$36MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/09/26 10-QQ3 ended 09/30/2511/14/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report10/13/26 8-KCurrent report07/07/26 8-KCurrent report06/18/26 8-KCurrent report05/04/26 8-KCurrent report04/22/26

Prospectuses and Registrations

424B3Prospectus08/21/26 S-8Registration of securities for employees03/31/26 424B5Prospectus supplement03/19/26 424B5Prospectus supplement03/17/26 S-3Shelf registration12/29/25

Proxies

DEF 14ADefinitive proxy04/30/26 DEF 14ADefinitive proxy08/29/25 PRE 14APreliminary proxy08/19/25 DEF 14ADefinitive proxy06/02/25 DEF 14ADefinitive proxy05/30/24

Ownership

Form 4Insider transaction09/18/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26

Other

25-NSERemoval from listing10/22/26 EFFECTRequest for effectiveness01/07/26 CORRESPCorrespondence with the SEC01/05/26 UPLOADLetter from the SEC01/02/26 EFFECTRequest for effectiveness09/30/25